Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
OVID
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -22.4%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
therapeutics
nasdaq
2023
last
rating
york
high
trading
compared
period
biopharmaceutical
announced
globe
newswire
today
lives
people
epilepsies
developing
medicines
OVID
Ovid Therapeutics Inc. Common Stock
StonvexStonvexStonvexStonvex